Averin Capital Acquisition

Leadership is credible for sourcing in the targeted health and technology arenas. CEO and Chairman David Berry MD PhD has a long record as a company builder and investor. The independent board adds sector depth with Mary T. Szela and others.

Still, SPAC incentive structures can misalign sponsor and public shareholder outcomes if a deal is pursued mainly to crystallize the promote rather than to maximize long term value. Until a target is disclosed, execution quality remains unproven.